TLSI
TriSalus Life Sciences (TLSI)
$49
About TriSalus Life Sciences (TLSI)
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
Details
Daily high
$4.54
Daily low
$4.44
Price at open
$4.48
52 Week High
$7.95
52 Week Low
$3.42
Market cap
275.3M
Dividend yield
0.00%
Volume
153,884
Avg. volume
181,641
P/E ratio
-2.45
TriSalus Life Sciences News
Details
Daily high
$4.54
Daily low
$4.44
Price at open
$4.48
52 Week High
$7.95
52 Week Low
$3.42
Market cap
275.3M
Dividend yield
0.00%
Volume
153,884
Avg. volume
181,641
P/E ratio
-2.45